This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Brugada Syndrome
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

This prospective study evaluates the methodology and results of epicardial mapping/ablation in a large series of consecutive selected BrS patients and to verify if RFA could normalize the consequences of a genetic disease.

Provided treatments

  • Procedure: mapping/ablation
  • Drug: Ajmaline
  • Procedure: ablation
  • Procedure: mapping

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02641431. The sponsor of the trial is IRCCS Policlinico S. Donato and it is looking for 135 volunteers for the current phase.
Official trial title:
Electrical Substrate Elimination in Brugada Syndrome. Results in 135 Consecutive Patients